tradingkey.logo

tradingkey.logo
怜玢


Genelux Corp

GNLX
りォッチリストに远加
1.865USD
-0.035-1.84%
終倀 11-13 16:00ET
84.39M時䟡総額
損倱額盎近12ヶ月PER

Genelux Corpに぀いお 䌁業名

Genelux Corporation is a late clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its clinical and preclinical product candidates are intended to selectively kill tumor cells and induce a robust immune response against a patient’s tumor neoantigens. Its product candidate, Olvi-Vec (olvimulogene nanivacirepvec), is a proprietary, modified strain of the vaccinia virus (VACV), a stable deoxyribonucleic acid (DNA) virus with a large engineering capacity. Olvi-Vec is developed for the treatment of multiple cancers based on the results of preclinical studies that suggest Olvi-Vec has the potential to infect and directly kill a wide range of tumor cell types in vitro and in vivo and produce an anti-tumor immune response. Its portfolio also include oncolytic vaccinia immunotherapy clinical candidates.

Genelux Corp プロフィヌル


䌁業コヌドGNLX
䌚瀟名Genelux Corp
䞊堎日Jan 26, 2023
最高経営責任者「CEO」Zindrick (Thomas)
埓業員数24
蚌刞皮類Ordinary Share
決算期末Jan 26
本瀟所圚地2625 Townsgate Road, Suite 230
郜垂WESTLAKE VILLAGE
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号91361
電話番号18052679889
りェブサむトhttps://genelux.com/
䌁業コヌドGNLX
䞊堎日Jan 26, 2023
最高経営責任者「CEO」Zindrick (Thomas)

Genelux Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. John Thomas, Ph.D.
Dr. John Thomas, Ph.D.
Independent Director
Independent Director
478.91K
+3.84%
Mr. Eric Groen, J.D.
Mr. Eric Groen, J.D.
General Counsel, Corporate Secretary, Chief Compliance Officer, Head of Business Development
General Counsel, Corporate Secretary, Chief Compliance Officer, Head of Business Development
233.96K
--
Dr. Joseph Cappello, Ph.D.
Dr. Joseph Cappello, Ph.D.
Chief Technical Officer
Chief Technical Officer
194.67K
-5.60%
Ms. Mary Mirabelli
Ms. Mary Mirabelli
Independent Director
Independent Director
80.41K
+35.33%
Mr. James L. (Jim) Tyree
Mr. James L. (Jim) Tyree
Lead Independent Director
Lead Independent Director
74.20K
+38.29%
Mr. John W. Smither
Mr. John W. Smither
Independent Director
Independent Director
69.12K
-17.36%
Mr. Ralph Smalling
Mr. Ralph Smalling
Head - Regulatory
Head - Regulatory
20.15K
-0.95%
Mr. Thomas D. Zindrick, J.D.
Mr. Thomas D. Zindrick, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Paul Scigalla, M.D., Ph.D.
Dr. Paul Scigalla, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Tony Yu, Ph.D.
Dr. Tony Yu, Ph.D.
Senior Vice President - Clinical Development
Senior Vice President - Clinical Development
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. John Thomas, Ph.D.
Dr. John Thomas, Ph.D.
Independent Director
Independent Director
478.91K
+3.84%
Mr. Eric Groen, J.D.
Mr. Eric Groen, J.D.
General Counsel, Corporate Secretary, Chief Compliance Officer, Head of Business Development
General Counsel, Corporate Secretary, Chief Compliance Officer, Head of Business Development
233.96K
--
Dr. Joseph Cappello, Ph.D.
Dr. Joseph Cappello, Ph.D.
Chief Technical Officer
Chief Technical Officer
194.67K
-5.60%
Ms. Mary Mirabelli
Ms. Mary Mirabelli
Independent Director
Independent Director
80.41K
+35.33%
Mr. James L. (Jim) Tyree
Mr. James L. (Jim) Tyree
Lead Independent Director
Lead Independent Director
74.20K
+38.29%
Mr. John W. Smither
Mr. John W. Smither
Independent Director
Independent Director
69.12K
-17.36%

よくある質問

Genelux Corpの䞊䜍5名の株䞻は誰ですか


Genelux Corpの䞊䜍5名の株䞻は以䞋のずおりです。Dr. John Thomas, Ph.D.

Genelux CorpGNLXの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Genelux Corpの株匏を保有しおいる機関は186瀟あり、保有株匏の総垂堎䟡倀は玄13.88Mで、党䜓の30.96%を占めおいたす。2025Q4ず比范しお、機関の持ち株は3967281.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。